Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Neoplasms 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Hematologic Neoplasms 1Heart Failure 1Fallopian Tube Neoplasms 1Cardiomyopathies 1Brenner Tumor 1

Interventions

Standard of Care 2Blood Specimen Collection 2epicatechin gallate 1Vascular Stiffness 1Valsartan 1Therapeutics 1Specimen Handling 1Restraint, Physical 1Pulse Wave Analysis 1Practice Guidelines as Topic 1Mesenchymal Stem Cell Transplantation 1Exercise 1Electronic Health Records 1Electrocardiography 1Echocardiography 1Carvedilol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Cardiomyopathies × Mesenchymal Stem Cell Transplantation × Clear all
NCT02962661 2026-01-07

Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

M.D. Anderson Cancer Center

Phase 1 Recruiting
72 enrolled
Other hematologic neoplasm

Heart Failure, Cardiomyopathies, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡